Table 3.
Subjective state scores before and after subacute treatment with either placebo or pramipexole. Values in each group represent means with standard deviations in parentheses. The column on the right-hand side displays ANCOVA results.
| Placebo | Pramipexole | ||||
|---|---|---|---|---|---|
| Baseline | On-Drug | Baseline | On-Drug | ANCOVA Results | |
| BFS | 13.8 (11.2) | 14.8 (14.2) | 11.7 (12.4) | 15.4 (14.7) | F(1.37) = 0.4, p = 0.51 |
| STAI state | 28.6 (6.1) | 29.1 (5.2) | 28.9 (6.5) | 27.8 (5.4) | F(1.37) = 1.2, p = 0.28 |
| BDI | 2.8 (3.3) | 2.7 (3.3) | 1.9 (2.5) | 2.9 (3.4) | F(1.36) = 0.9, p = 0.36 |
| PANAS pos. present | 32.5 (8.6) | 32.6 (7.9) | 36.4 (7.7) | 34.5 (8.3) | F(1.37) = 0.5, p = 0.50 |
| PANAS neg. present | 11.3 (1.3) | 11.8 (2.7) | 11.2 (1.5) | 11.0 (1.5) | F(1.37) = 2.1, p = 0.15 |
| PANAS pos. today | 32.9 (8.2) | 32.3 (8.1) | 36.8 (8.0) | 34.8 (9.1) | F(1.37) = 0.1, p = 0.73 |
| PANAS neg. today | 11.6 (1.7) | 11.8 (2.4) | 11.4 (2.0) | 11.4 (1.7) | F(1.37) = 0.4, p = 0.55 |
| PANAS pos. last week | 34.2 (7.6) | 34.6 (9.3) | 37.7 (9.2) | 37.0 (7.7) | F(1.37) < 0.001, p > 0.99 |
| PANAS neg. last week | 14.1 (4.1) | 12.6 (2.7) | 13.3 (2.8) | 12.7 (3.2) | F(1.37) = 0.1, p = 0.71 |
| SHAPS | 0.2 (0.7) | 0.3 (0.7) | 0.5 (1.0) | 0.7 (1.6) | F(1.37) = 0.3, p = 0.61 |
| TEPS total | 79.3 (8.2) | 79.2 (10.0) | 85.3 (10.0) | 82.1 (9.5) | F(1.37) = 0.7, p = 0.42 |
| TEPS anticipatory | 42.1 (4.9) | 42.3 (5.4) | 47.1 (6.1) | 44.6 (5.5) | F(1.37) = 0.8, p = 0.38 |
| TEPS consummatory | 37.3 (4.4) | 36.8 (5.4) | 38.1 (5.6) | 37.5 (5.9) | F(1.37) = 0.01, p = 0.91 |
| OXH | 132.4 (19.6) | 132.0 (19.7) | 134.8 (19.2) | 138.0 (18.4) | F(1.37) = 3.1, p = 0.08 |
| QUIP | 16.6 (11.2) | 13.8 (10.4) | 12.3 (8.3) | 8.7 (8.5) | F(1.37) = 1.0, p = 0.33 |
BFS: Befindlichkeitsskala; STAI: state-trait anxiety inventory; BDI: Beck depression inventory; PANAS: positive and negative affect schedule; SHAPS: Snaith-Hamilton pleasure scale; TEPS: temporal experience of pleasure scale; OXH: Oxford happiness questionnaire; QUIP: questionnaire for impulsive-compulsive disorders in Parkinson’s disease rating scale.